Transcatheter pulmonary valve replacement is a complementary strategy to surgical replacement that may diminish late morbidity.
Supports consideration in select congenital cases; leaves open need for randomized durability data.
Transcatheter pulmonary valve replacement is fast becoming an accepted alternative to repeat surgical pulmonary valve replacement for selected patients and therefore a complementary strategy in the long-term management of those requiring surgical pulmonary valve replacement. With a combined surgical and percutaneous approach, late morbidity for some of these patients may be diminished. This manuscript will review the current indications for this procedure, its limitations, and its benefits.
No takes yet. Share an insight, caveat, or question.
Ringewald et al. (2012) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: